Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cell Conditioned Medium for Chronic Stroke
jRCT1051250144Recruiting
- Sponsor
- Azabu-Juban TT Heart Clinic
- Start
- Nov 2025
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of human-derived mesenchymal stem cell conditioned medium in stroke, sponsored by Azabu-Juban TT Heart Clinic. Primary endpoints: Clinical condition and medical history, Fugl-Meyer Assessment (FMA) and 9 more. Started Nov 2025; status: recruiting.
02
Drugs
human-derived mesenchymal stem cell conditioned medium
03
Conditions
stroke
Beyond the preview
Go deeper on jRCT1051250144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051250144.